PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT • 2.1 Preface • 2.2 Preface • 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 04: MARKET SIZING • Market definition • Market sizing 2018 • Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 06: MARKET SEGMENTATION BY PRODUCT • Market segmentation by product • Comparison by product • Wearable devices - Market size and forecast 2018-2023 • Non-wearable devices - Market size and forecast 2018-2023 • Market opportunity by product PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE • Geographic segmentation • Geographic comparison • North America - Market size and forecast 2018-2023 • Europe - Market size and forecast 2018-2023 • Asia - Market size and forecast 2018-2023 • ROW - Market size and forecast 2018-2023 • Key leading countries • Market opportunity PART 09: DECISION FRAMEWORK PART 10: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 11: MARKET TRENDS • Growing focus on collaborations for business expansion • Integration of AI and RADAR technology in glucose monitoring • Growing funding for non-invasive glucose monitoring technology PART 12: VENDOR LANDSCAPE • Overview • Landscape disruption • Competitive scenario PART 13: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Abbott Laboratories • Cnoga Medical Ltd. • Evia Medical Technologies • Helo Corp. • Integrity Applications Inc. • Nemaura Medical Inc. • RISE Life Science Corp. • Taiwan Biophotonic Co. PART 14: APPENDIX • Research methodology • List of abbreviations • Definition of market positioning of vendors PART 15: EXPLORE TECHNAVIO   Exhibit 01: Product Overview Exhibit 02: Global medical devices market Exhibit 03: Segments of global medical devices market Exhibit 04: Market characteristics Exhibit 05: Market segments Exhibit 06: Market definition - Inclusions and exclusions checklist Exhibit 07: Market size 2018 Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 09: Global market: Year-over-year growth 2019-2023 (%) Exhibit 10: Five forces analysis 2018 Exhibit 11: Five forces analysis 2023 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2018 Exhibit 18: Product - Market share 2018-2023 (%) Exhibit 19: Comparison by product Exhibit 20: Wearable devices - Market size and forecast 2018-2023 ($ millions) Exhibit 21: Wearable devices - Year-over-year growth 2019-2023 (%) Exhibit 22: Non-wearable devices - Market size and forecast 2018-2023 ($ millions) Exhibit 23: Non-wearable devices - Year-over-year growth 2019-2023 (%) Exhibit 24: Market opportunity by product Exhibit 25: Customer landscape Exhibit 26: Market share by geography 2018-2023 (%) Exhibit 27: Geographic comparison Exhibit 28: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 29: North America - Year-over-year growth 2019-2023 (%) Exhibit 30: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 31: Europe - Year-over-year growth 2019-2023 (%) Exhibit 32: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 33: Asia - Year-over-year growth 2019-2023 (%) Exhibit 34: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 35: ROW - Year-over-year growth 2019-2023 (%) Exhibit 36: Key leading countries Exhibit 37: Market opportunity Exhibit 38: Impact of drivers and challenges Exhibit 39: Vendor landscape Exhibit 40: Landscape disruption Exhibit 41: Vendors covered Exhibit 42: Vendor classification Exhibit 43: Market positioning of vendors Exhibit 44: Abbott Laboratories - Vendor overview Exhibit 45: Abbott Laboratories - Business segments Exhibit 46: Abbott Laboratories - Organizational developments Exhibit 47: Abbott Laboratories - Geographic focus Exhibit 48: Abbott Laboratories - Segment focus Exhibit 49: Abbott Laboratories - Key offerings Exhibit 50: Abbott Laboratories - Key customers Exhibit 51: Cnoga Medical Ltd. - Vendor overview Exhibit 52: Cnoga Medical Ltd. - Key offerings Exhibit 53: Cnoga Medical Ltd. - Key customers Exhibit 54: Evia Medical Technologies - Vendor overview Exhibit 55: Evia Medical Technologies - Business segments Exhibit 56: Evia Medical Technologies - Key offerings Exhibit 57: Evia Medical Technologies - Key customers Exhibit 58: Helo Corp. - Vendor overview Exhibit 59: Helo Corp. - Key offerings Exhibit 60: Helo Corp. - Key customers Exhibit 61: Integrity Applications Inc. - Vendor overview Exhibit 62: Integrity Applications Inc. - Organizational developments Exhibit 63: Integrity Applications Inc. - Geographic focus Exhibit 64: Integrity Applications Inc. - Key offerings Exhibit 65: Integrity Applications Inc. - Key customers Exhibit 66: Nemaura Medical Inc. - Vendor overview Exhibit 67: Nemaura Medical Inc. - Organizational developments Exhibit 68: Nemaura Medical Inc. - Key offerings Exhibit 69: Nemaura Medical Inc. - Key customers Exhibit 70: RISE Life Science Corp. - Vendor overview Exhibit 71: RISE Life Science Corp. - Business segments Exhibit 72: RISE Life Science Corp. - Organizational developments Exhibit 73: RISE Life Science Corp. - Key offerings Exhibit 74: RISE Life Science Corp. - Key customers Exhibit 75: Taiwan Biophotonic Co. - Vendor overview Exhibit 76: Taiwan Biophotonic Co. - Organizational developments Exhibit 77: Taiwan Biophotonic Co. - Key offerings Exhibit 78: Taiwan Biophotonic Co. - Key customers Exhibit 79: Validation techniques employed for market sizing Exhibit 80: Definition of market positioning of vendors

Abbott Laboratories, Cnoga Medical Ltd., Evia Medical Technologies, Helo Corp., Integrity Applications Inc., Nemaura Medical Inc., RISE Life Science Corp., and Taiwan Biophotonic Co.